The mean distance between the LFCN and the ASIS was 15.6 ± 4.2 mm (range 2.2–38.7). The nerve passed under the IL in 198 cases (82.5%), whereas in 44 cases (17.5%), it passed through the IL ...
January 21, 2025--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use. This clearance provides physicians ...
[Image from Nalu Medical] Nalu Medical announced today that the FDA cleared expanded labeling of its peripheral nerve system to include whole-body MRI use. The clearance gives physicians greater ...
Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use. This clearance provides physicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results